Generic drug giant Mylan Inc. (NASDAQ:MYL) on Thursday reported fourth-quarter profits rose 11 percent, to $180.2 million from $162 million a year earlier, as CEO Heather Bresch said the Cecil-based company was poised for another “substantial transaction” this year. Mylan Inc (NASDAQ:MYL) stock opened at $54.14 in last session, and closed at $56.27, while the day range of stock is $53.64 – $57.07. The stock showed a positive weekly performance of 7.67%.
Illumina, Inc. (NASDAQ:ILMN) cell-free DNA testing technology was more accurate than traditional techniques in diagnosing Down syndrome and Edwards syndrome. Illumina, Inc. (NASDAQ:ILMN) stock opened at $178.92, in last session and closed at $178.11, by gaining 0.80%. The 52 week range of the stock is $48.62 – $181.60. Company’s market capitalization is $22.85 billion.
Research analysts at Jefferies Group raised their price target on shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) from $30.00 to $36.00 in a report released on Thursday, Stock Ratings Network reports. Jefferies Group’s target price indicates a potential upside of 17.65% from the company’s current price. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) stock advanced 0.78% and finished the last session at $30.84. The EPS of the stock remained 2.23. Company’s market capitalization is $1.53 billion.
Argus raised their target price on shares of Actavis plc Ordinary Shares (NYSE:ACT) from $198.00 to $225.00 in a research note issued on Tuesday, Analyst Ratings Network reports. Actavis plc Ordinary Shares (NYSE:ACT) stock opened the session at $226.91, and closed the session at $227.15. The 52 week range of the stock remained $84.41 – $230.77 and the day range was $225.45 $229.30.
Leave a Reply